ReviewJournal of experimental & clinical cancer research : CR2020

Mechanisms of hyperprogressive disease after immune checkpoint inhibitor therapy: what we (don't) know.

Simone Camelliti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.